231 related articles for article (PubMed ID: 29142974)
21. Short-term duration of diabetic retinopathy as a predictor for development of diabetic kidney disease.
Duan J; Liu D; Zhao Z; Liang L; Pan S; Tian F; Yu P; Li G; Liu Z
J Transl Int Med; 2023 Dec; 11(4):449-458. PubMed ID: 38130638
[TBL] [Abstract][Full Text] [Related]
22. Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease.
Zhang H; Hu W; Zhang G
Int Urol Nephrol; 2020 Aug; 52(8):1517-1522. PubMed ID: 32458209
[TBL] [Abstract][Full Text] [Related]
23. Serum branched chain amino acids: an effective indicator of diabetic kidney disease.
Liu M; Yang Y; Liu Y; Peng X; Hou Y; Zhang X; Sun H; Shan C
Front Endocrinol (Lausanne); 2023; 14():1269633. PubMed ID: 38089615
[TBL] [Abstract][Full Text] [Related]
24. Risk Factors for the Development and Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Advanced Diabetic Retinopathy.
Yun KJ; Kim HJ; Kim MK; Kwon HS; Baek KH; Roh YJ; Song KH
Diabetes Metab J; 2016 Dec; 40(6):473-481. PubMed ID: 27766790
[TBL] [Abstract][Full Text] [Related]
25. Association of Succinate and Adenosine Nucleotide Metabolic Pathways with Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
Jung I; Nam S; Lee DY; Park SY; Yu JH; Seo JA; Lee DH; Kim NH
Diabetes Metab J; 2024 Jul; ():. PubMed ID: 38945526
[TBL] [Abstract][Full Text] [Related]
26. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey.
Duan JY; Duan GC; Wang CJ; Liu DW; Qiao YJ; Pan SK; Jiang DK; Liu Y; Zhao ZH; Liang LL; Tian F; Liu ZS
BMC Nephrol; 2020 Apr; 21(1):115. PubMed ID: 32245423
[TBL] [Abstract][Full Text] [Related]
28. Optimization of kidney dysfunction prediction in diabetic kidney disease using targeted metabolomics.
Ibarra-González I; Cruz-Bautista I; Bello-Chavolla OY; Vela-Amieva M; Pallares-Méndez R; Ruiz de Santiago Y Nevarez D; Salas-Tapia MF; Rosas-Flota X; González-Acevedo M; Palacios-Peñaloza A; Morales-Esponda M; Aguilar-Salinas CA; Del Bosque-Plata L
Acta Diabetol; 2018 Nov; 55(11):1151-1161. PubMed ID: 30173364
[TBL] [Abstract][Full Text] [Related]
29. A new tool to detect kidney disease in Chinese type 2 diabetes patients: comparison of EZSCAN with standard screening methods.
Ozaki R; Cheung KK; Wu E; Kong A; Yang X; Lau E; Brunswick P; Calvet JH; Deslypere JP; Chan JC
Diabetes Technol Ther; 2011 Sep; 13(9):937-43. PubMed ID: 21714678
[TBL] [Abstract][Full Text] [Related]
30. Could serum zonulin be an intestinal permeability marker in diabetes kidney disease?
Carpes LS; Nicoletto BB; Canani LH; Rheinhemer J; Crispim D; Souza GC
PLoS One; 2021; 16(6):e0253501. PubMed ID: 34170951
[TBL] [Abstract][Full Text] [Related]
31. The hidden diabetic kidney disease in a university hospital-based population: a real-world data analysis.
Marques M; López-Sánchez P; Tornero F; Gargantilla P; Maroto A; Ortiz A; Portolés J
Clin Kidney J; 2022 Oct; 15(10):1865-1871. PubMed ID: 36158147
[TBL] [Abstract][Full Text] [Related]
32. The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease.
Zhang Q; Zhang Y; Zeng L; Chen G; Zhang L; Liu M; Sheng H; Hu X; Su J; Zhang D; Lu F; Liu X; Zhang L
Front Pharmacol; 2021; 12():757508. PubMed ID: 34899312
[No Abstract] [Full Text] [Related]
33. Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.
Penno G; Russo E; Garofolo M; Daniele G; Lucchesi D; Giusti L; Sancho Bornez V; Bianchi C; Dardano A; Miccoli R; Del Prato S
Diabetologia; 2017 Jun; 60(6):1102-1113. PubMed ID: 28357502
[TBL] [Abstract][Full Text] [Related]
34. Diabetic Nephropathy Can Be Treated with Calcium Dobesilate by Alleviating the Chronic Inflammatory State and Improving Endothelial Cell Function.
Zhou Y; Qi C; Li S; Shao X; Mou S; Ni Z
Cell Physiol Biochem; 2018; 51(3):1119-1133. PubMed ID: 30476916
[TBL] [Abstract][Full Text] [Related]
35. Newly established LC-MS/MS method for measurement of plasma BH4 as a predictive biomarker for kidney injury in diabetes.
Deng C; Wang S; Niu Z; Ye Y; Gao L
Free Radic Biol Med; 2022 Jan; 178():1-6. PubMed ID: 34808334
[TBL] [Abstract][Full Text] [Related]
36. SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes.
Wheeler DC; James J; Patel D; Viljoen A; Ali A; Evans M; Fernando K; Hicks D; Milne N; Newland-Jones P; Wilding J;
Diabetes Ther; 2020 Dec; 11(12):2757-2774. PubMed ID: 32996085
[TBL] [Abstract][Full Text] [Related]
37. The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan.
Wang Y; Peng W; Zhang X; Qiao H; Wang L; Xu Z; Wu C
J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27638852
[TBL] [Abstract][Full Text] [Related]
38. Consistent effects of empagliflozin on cardiovascular and kidney outcomes irrespective of diabetic kidney disease categories: Insights from the EMPA-REG OUTCOME trial.
Wanner C; Inzucchi SE; Zinman B; Koitka-Weber A; Mattheus M; George JT; von Eynatten M; Hauske SJ;
Diabetes Obes Metab; 2020 Dec; 22(12):2335-2347. PubMed ID: 32744354
[TBL] [Abstract][Full Text] [Related]
39. UPLC-MS-based urine nontargeted metabolic profiling identifies dysregulation of pantothenate and CoA biosynthesis pathway in diabetic kidney disease.
Ma T; Liu T; Xie P; Jiang S; Yi W; Dai P; Guo X
Life Sci; 2020 Oct; 258():118160. PubMed ID: 32730837
[TBL] [Abstract][Full Text] [Related]
40. Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study.
Cid Ruzafa J; Paczkowski R; Boye KS; Di Tanna GL; Sheetz MJ; Donaldson R; Breyer MD; Neasham D; Voelker JR
Int J Clin Pract; 2015 Aug; 69(8):871-82. PubMed ID: 26011029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
